Hanson McClain Advisors »

Aeglea Biotherapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $536 32 16.78
2025-06-30 $450 30 15.00
2025-03-31 $195 13 15.00
2024-12-31 $197 9 21.89
2024-09-30 $206 7 29.43

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics